
BlossomHill Therapeutics fell 9.6% from $16.00 to $14.46, behind the S&P 500's −3.0%. Its worst day was Oct 6 (−13.3%), and its low came Nov 5 at $12.35.
Aug 7, 2026 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-8.75 missed the $-0.77 estimate on $0.00 revenue.
−4.0% · S&P 500 +0.1%
Where it ended: a close of $14.46 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 23, 2026 (EPS est. $-0.90).
Story events cover the past 12 months · Times ET
Nothing in the past 12 months.
All BLSM dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BLSM and SPY from Benzinga historical bars. Not investment advice.